• Skip to main content
  • Skip to secondary menu
  • Skip to primary sidebar
  • Skip to secondary sidebar
  • Skip to footer

  • Opinion
  • Health IT
    • Behavioral Health
    • Care Coordination
    • EMR/EHR
    • Interoperability
    • Patient Engagement
    • Population Health Management
    • Revenue Cycle Management
    • Social Determinants of Health
  • Digital Health
    • AI
    • Blockchain
    • Precision Medicine
    • Telehealth
    • Wearables
  • Life Sciences
  • Investments
  • M&A
  • Value-based Care
    • Accountable Care (ACOs)
    • Medicare Advantage

Cigna’s Evernorth Expands Digital Health Formulary with Addition of Omada MSK by Physera

by Fred Pennic 10/07/2020 Leave a Comment

  • LinkedIn
  • Twitter
  • Facebook
  • Email
  • Print
Cigna’s Evernorth Expands Digital Health Formulary with Addition of Omada MSK by Physera

What You Should Know:

– Cigna Corporation’s health services segment, Evernorth expands its digital health formulary with the addition of Omada MSK by Physera.

– Omada MSK by Physera joins Omada’s existing formulary programs for diabetes prevention, type 2 diabetes, and hypertension.


Cigna Corporation’s health services segment Evernorth today announced the expansion of its industry-first Digital Health Formulary, adding Omada Health’s program for at-home physical therapy and personalized coaching for chronic pain to the platform. Omada MSK by Physera joins Omada’s existing formulary programs for diabetes prevention, type 2 diabetes, and hypertension.


Evernorth Health Services Background

Evernorth provides a distinct and dedicated platform for the distribution of health solutions geared toward health plans, employers, and government organizations – inclusive of those without Cigna medical insurance. This enables Evernorth to partner deeply with, and provide unmatched and focused support to these groups, all guided by its unwavering commitment to make health care better. 

To date, health plans covering more than 20 million Americans offer solutions from Evernorth’s Digital Health Formulary to their members. Plan sponsors can choose to invest and deploy individual solutions, or a combination of programs on the platform. In addition to rigorous measurement from physicians, pharmacists, and health research scientists, programs on the formulary are also evaluated by user-experience experts. People using programs on the Digital Health Formulary may also receive support from specialist pharmacists to further optimize the potential health benefits of the chosen solutions.


Availability

The musculoskeletal program will be available to formulary customers beginning in 2021, giving Omada the broadest range of programs on the industry-leading platform. Created in 2019, the Digital Health Formulary features solutions that are evaluated and measured on clinical effectiveness, usability, scalability, and interoperability.


  • LinkedIn
  • Twitter
  • Facebook
  • Email
  • Print

Tagged With: digital health formulary, Omada Health

Tap Native

Get in-depth healthcare technology analysis and commentary delivered straight to your email weekly

Reader Interactions

Primary Sidebar

Subscribe to HIT Consultant

Latest insightful articles delivered straight to your inbox weekly.

Submit a Tip or Pitch

Featured Insights

Aligning IT & Clinical Teams: How to Reduce Friction and Improve Communication

Most-Read

UT Austin is Building the Nation's First 'AI-Native' Hospital, Backed by $750M

UT Austin is Building the Nation’s First ‘AI-Native’ Hospital, Backed by $750M

Oracle Lays Off 539 Kansas City Employees as Focus Shifts to AI Data Centers

Oracle Lays Off 539 Kansas City Employees as Focus Shifts to AI Data Centers

SAMHSA and ONC Invest $20M in Behavioral Health IT Initiative

HHS Reverses 2024 Tech Reorganization: Why HHS Just Stripped AI and Cyber Operations Out of the ONC

How Small Medical Practices Can Build HIPAA-Aligned DevSecOps Without Enterprise Budgets

How Small Medical Practices Can Build HIPAA-Aligned DevSecOps Without Enterprise Budgets

Insilico Medicine and Eli Lilly Form $2.75B AI Drug Discovery Collaboration

Insilico Medicine and Eli Lilly Form $2.75B AI Drug Discovery Collaboration

Microsoft Copilot Health, Integrates Apple Health, Oura, and 50,000 EHRs in New AI Push

Microsoft Launches Copilot Health, Integrates Apple Health, Oura, and 50,000 EHRs in New AI Push

Health Recovery Solutions (HRS) Acquires Rimidi for Chronic Care Management and RPM Integration

Health Recovery Solutions (HRS) Acquires Rimidi for Chronic Care Management and RPM Integration

RadNet Subsidiary DeepHealth Acquires French Radiology AI Leader Gleamer

RadNet’s $269M AI Play: DeepHealth Acquires French AI Gleamer

Walgreens Launches Virtual Weight Management Platform for Self-Pay GLP-1 Patients

Walgreens Launches Virtual Weight Management Platform for Self-Pay GLP-1 Patients

KLAS Digital Pathology 2026 Report: Top IMS, Scanner, and AI Vendors Evaluated

KLAS Digital Pathology 2026 Report: Top IMS, Scanner, and AI Vendors Evaluated

Secondary Sidebar

Footer

Company

  • About Us
  • 2026 Editorial Calendar
  • Advertise with Us
  • Reprints and Permissions
  • Op-Ed Submission Guidelines
  • Contact
  • Subscribe

Editorial Coverage

  • Opinion
  • Health IT
    • Care Coordination
    • EMR/EHR
    • Interoperability
    • Population Health Management
    • Revenue Cycle Management
  • Digital Health
    • Artificial Intelligence
    • Blockchain Tech
    • Precision Medicine
    • Telehealth
    • Wearables
  • Startups
  • Value-Based Care
    • Accountable Care
    • Medicare Advantage

Connect

Subscribe to HIT Consultant Media

Latest insightful articles delivered straight to your inbox weekly

Copyright © 2026. HIT Consultant Media. All Rights Reserved. Privacy Policy |